International

Facebook acts like a social media platform but thinks like a tech titan

The IP community expected a re-vamped patent strategy from the Silicon Valley giant after it poached key members of Google’s patent team a few years back. Lo and Chan haven’t disappointed.

Facebook acts like a social media platform but thinks like a tech titan
Final call to take part in this year’s IAM benchmarking survey
26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market

Covid-19 emergency may expose compulsory licensing limits
24 Mar 2020

Covid-19 emergency may expose compulsory licensing limits

Government responses to the pandemic could include increased focus on obligatory sharing of patented inventions, but regulatory data exclusivities might serve as a barrier in both Europe and the United States.

Latest

View all
20 Mar 2020

Fortress may have struck gold with its Theranos patents

Data analysis reveals that the IP portfolio created by Elizabeth Holmes’ now defunct company is of high-quality and has widespread geographic coverage Read more

18 Mar 2020

Help us map the latest developments in the global IP market

There’s not long left to answer our annual IP benchmarking survey Read more

10 Mar 2020

The key IP takeaways from medtech’s largest buyout in years

Thermo Fisher has agreed to spend $11.5 billion on Qiagen to acquire complementary diagnostics and bioinformatics assets Read more

28 Feb 2020

The US has a mountain to climb in 5G network equipment

Patent analysis shows that American companies would need to make big plays if they want to catch the Chinese, but it is almost certainly too late already Read more

Designs

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

18 Dec 2019

US lawmakers sound alarm on China’s WIPO ambitions

China has nominated agency insider Wang Binying for the director general post, but the US is said to favour Singapore's candidate Read more

13 Feb 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco Read more

30 Jan 2019

Winners of the inaugural Global IP Awards named at gala dinner in London

Law and attorney firms from around the world recognised for their outstanding work in litigation, prosecution and transactions during 2018 Read more

Finance

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

13 Feb 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco Read more

9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

Frand/SEPS

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

13 Jun 2019

How Apple uses patents to win

The iPhone giant’s portfolio is at the heart of the defence it plays when the subject of an assertion – and analysis shows that much of it has been acquired rather than grown organically Read more

13 Feb 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco Read more

25 Jan 2019

Treat IP rights as property to maximise their value, Huawei CEO urges

In a rare public appearance, the Chinese telecom’s founder and CEO, Ren Zhengfei, reaffirms commitment to respect third-party patents and explains why paying more than the competition will keep his company ahead Read more

Law & Policy

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

6 Feb 2020

Iancu makes US concerns about possible Chinese WIPO leadership clear

USPTO head tells Washington DC event that the next head of the organisation must come from a country that “respects intellectual property rights” Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

18 Dec 2019

US lawmakers sound alarm on China’s WIPO ambitions

China has nominated agency insider Wang Binying for the director general post, but the US is said to favour Singapore's candidate Read more

Litigation

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

29 Jan 2020

CJEU Advocate General recommends throwing out innovator-friendly Neurim decision

If the full court agrees with the opinion, which relates to the crucial Santen SPC case, it would limit the IP protection open to second medical use innovations in the EU Read more

16 Jan 2020

Breaking: EPO Board of Appeal upholds invalidation of Broad’s CRISPR-Cas9 patent

Surprise move means Enlarged Board will not now be asked to consider key questions that were referred to it yesterday Read more

Market Developments

View all
25 Feb 2020

Despite a drop-off in deal numbers, 2019 was a great year for biopharma IP owners

Last year’s M&A and licensing figures suggest that there is a sellers' market in many types of life sciences assets Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

14 Feb 2020

Help to choose the IP Hall of Fame inductees for 2020

Nominate someone who deserves recognition for their outstanding, long-term contribution to the IP world Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

Non-Practising Entities

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

9 Jan 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases Read more

10 Jul 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month Read more

Patent Pools

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

21 Jan 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade Read more

24 Jul 2019

CRISPR patent pool will do little to quash licensing uncertainties

New initiative may help the Broad and MilliporeSigma strike more licensing deals, but is unlikely to heal the deeper fractures in the CRISPR landscape Read more

5 Jul 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’ Read more

Patents Law

View all
25 Feb 2020

Despite a drop-off in deal numbers, 2019 was a great year for biopharma IP owners

Last year’s M&A and licensing figures suggest that there is a sellers' market in many types of life sciences assets Read more

21 Feb 2020

Slowly and quietly, Shopify’s patent strategy is evolving

Canada’s tech darling is finally creating a meaningful portfolio on the back of a surging market capitalisation, but it still lags rivals – actual and potential Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

14 Feb 2020

Help to choose the IP Hall of Fame inductees for 2020

Nominate someone who deserves recognition for their outstanding, long-term contribution to the IP world Read more

Strategy

View all
25 Feb 2020

Despite a drop-off in deal numbers, 2019 was a great year for biopharma IP owners

Last year’s M&A and licensing figures suggest that there is a sellers' market in many types of life sciences assets Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

14 Feb 2020

It’s a tight race for autonomous driving patent leadership

New analysis gives unparalleled insight into the key players in self-drive technologies and shows Waymo, Toyota, GM and Ford vying for top spot Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

Technology Licensing

View all
25 Feb 2020

Despite a drop-off in deal numbers, 2019 was a great year for biopharma IP owners

Last year’s M&A and licensing figures suggest that there is a sellers' market in many types of life sciences assets Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

21 Jan 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade Read more

Trade Secrets

View all
25 Feb 2020

Despite a drop-off in deal numbers, 2019 was a great year for biopharma IP owners

Last year’s M&A and licensing figures suggest that there is a sellers' market in many types of life sciences assets Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

14 Feb 2020

Help to choose the IP Hall of Fame inductees for 2020

Nominate someone who deserves recognition for their outstanding, long-term contribution to the IP world Read more

6 Feb 2020

Iancu makes US concerns about possible Chinese WIPO leadership clear

USPTO head tells Washington DC event that the next head of the organisation must come from a country that “respects intellectual property rights” Read more

Valuation

View all
25 Feb 2020

Despite a drop-off in deal numbers, 2019 was a great year for biopharma IP owners

Last year’s M&A and licensing figures suggest that there is a sellers' market in many types of life sciences assets Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

14 Feb 2020

It’s a tight race for autonomous driving patent leadership

New analysis gives unparalleled insight into the key players in self-drive technologies and shows Waymo, Toyota, GM and Ford vying for top spot Read more

7 Feb 2020

Johnson & Johnson takes the patent lead in medtech innovation

The company has surpassed other healthcare powerhouses and kept Apple and Alphabet at bay, but a robust portfolio does not guarantee smooth sailing Read more

Find an expert